Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 113.26B | 119.26B | 111.38B | 94.83B | 70.46B | 66.14B |
Gross Profit | 21.42B | 22.53B | 20.98B | 17.21B | 12.16B | 11.22B |
EBITDA | 4.10B | 4.44B | 3.85B | 2.40B | 410.99M | -1.24B |
Net Income | 3.26B | 2.81B | 3.06B | 1.63B | -114.14M | -2.99B |
Balance Sheet | ||||||
Total Assets | 33.87B | 37.60B | 35.41B | 33.01B | 27.44B | 26.81B |
Cash, Cash Equivalents and Short-Term Investments | 3.28B | 6.13B | 3.99B | 4.08B | 3.21B | 2.93B |
Total Debt | 266.00M | 295.00M | 426.25M | 1.23B | 2.80B | 3.21B |
Total Liabilities | 21.05B | 23.12B | 22.72B | 21.97B | 17.92B | 16.91B |
Stockholders Equity | 12.82B | 14.48B | 12.69B | 11.04B | 9.52B | 9.90B |
Cash Flow | ||||||
Free Cash Flow | 579.14M | 3.23B | 2.67B | 2.54B | 259.59M | -2.27B |
Operating Cash Flow | 579.14M | 3.74B | 2.81B | 2.58B | 520.14M | -1.85B |
Investing Cash Flow | 0.00 | -546.00M | -90.07M | 50.27M | 201.53M | -331.83M |
Financing Cash Flow | 0.00 | -1.08B | -2.82B | -1.77B | -436.77M | 1.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥19.09B | 6.22 | 4.26% | 7.08% | -1.44% | ||
76 Outperform | ¥13.84B | 4.77 | 3.17% | 8.95% | 35.94% | ||
75 Outperform | ¥16.97B | 12.04 | 2.42% | 3.22% | 7.14% | ||
71 Outperform | ¥10.15B | 10.23 | 2.25% | 3.37% | -28.80% | ||
69 Neutral | ¥4.53B | 3.87 | 1.76% | 0.86% | 17.20% | ||
53 Neutral | C$4.46B | 3.86 | -22.83% | 4.40% | 8.13% | 2.00% |